Learn About Hemophagocytic Lymphohistiocytosis
- Familial hemophagocytic lymphohistiocytosis
- FHL
- Familial HLH
- Familial erythrophagocytic lymphohistiocytosis
- Familial histiocytic reticulosis
- HLH
Franco Locatelli practices in Rome, Italy. Mr. Locatelli and is rated as an Elite expert by MediFind in the treatment of Hemophagocytic Lymphohistiocytosis. His top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Leukemia, Juvenile Myelomonocytic Leukemia (JMML), Bone Marrow Transplant, and Splenectomy.
MD Anderson
Naval Daver is a Hematologist Oncology specialist and an Oncologist in Houston, Texas. Dr. Daver and is rated as an Elite provider by MediFind in the treatment of Hemophagocytic Lymphohistiocytosis. Their top areas of expertise are Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Leukemia, Bone Marrow Aspiration, and Bone Marrow Transplant.
Children's Hospital Medical Center
Michael Jordan is a Pediatric Hematologist Oncology provider in Cincinnati, Ohio. Dr. Jordan and is rated as an Elite provider by MediFind in the treatment of Hemophagocytic Lymphohistiocytosis. His top areas of expertise are Hemophagocytic Lymphohistiocytosis, Non-Langerhans-Cell Histiocytosis, Histiocytosis, Bone Marrow Transplant, and Osteotomy.
Summary: Claudin 18.2 protein, or CLDN18.2 is a protein found on cells in the digestive system. It is also found on some tumors. Researchers are looking at ways to attack CLDN18.2 to help control tumors. ASP2138 is thought to bind to CLDN18.2 and a protein on a type of immune cell called a T-cell. This tells the immune system to attack the tumor. ASP2138 is a potential treatment for people with stomach can...
Summary: This phase II trial tests the effects of ruxolitinib in combination with a de-intensified HLH-94 drug regimen has on patients with newly diagnosed hemophagocytic lymphohistiocytosis (HLH), a disorder caused by dysregulated immune responses (that is, immune responses that are too strong and cause inflammatory damage to normal tissues). The therapy used for HLH decreases the activity of the immune s...
Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center